
Inovio (INO) Pharmaceuticals Stock Fell 5% as Class Action Lawsuit Brews
Inovio Pharmaceuticals might see a plunge in its 2020 gains if a class action lawsuit proves the company deliberately misled the public. Yesterday, INO stock lost over 5% of its value.